ArticleOphthalmology and therapy2026

A Multicenter, Real-World Experience with Polyhexamethylene Biguanide (PHMB) 0.08% Monotherapy for Treating Acanthamoeba Keratitis: A Retrospective Review of 39 Cases.

Karl Anders Knutsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.